U.S., June 7 -- ClinicalTrials.gov registry received information related to the study (NCT07008664) titled 'Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer' on May 28.
Brief Summary: The purpose of this research study is to test a new process for diagnosing lung cancer by examining changes to your DNA that can be detected from a blood test. The information we learn by doing this study could potentially help people in the future.
Participants in this study will have blood samples collected, have their medical records reviewed by study personnel and fill out questionnaires at different time points during the study. Blood sample collection will occur during normal routine clinic visits. Partici...